Go Pro

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$13.08 +1.16 (+9.73%)
Closing price 04:00 PM Eastern
Extended Trading
$13.00 -0.08 (-0.61%)
As of 06:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DRTS vs. NVST, IRTC, ESTA, WRBY, and TMDX

Should you buy Alpha Tau Medical stock or one of its competitors? MarketBeat compares Alpha Tau Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Tau Medical include Envista (NVST), iRhythm Technologies (IRTC), Establishment Labs (ESTA), Warby Parker (WRBY), and TransMedics Group (TMDX).

How does Alpha Tau Medical compare to Envista?

Envista (NYSE:NVST) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Envista has a net margin of 2.41% compared to Alpha Tau Medical's net margin of 0.00%. Envista's return on equity of 7.11% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.41% 7.11% 3.91%
Alpha Tau Medical N/A -73.23%-52.90%

In the previous week, Envista had 4 more articles in the media than Alpha Tau Medical. MarketBeat recorded 7 mentions for Envista and 3 mentions for Alpha Tau Medical. Envista's average media sentiment score of 1.15 beat Alpha Tau Medical's score of -0.10 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Envista has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.72B1.67$47M$0.4168.15
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

Envista has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

2.7% of Alpha Tau Medical shares are held by institutional investors. 1.0% of Envista shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Envista currently has a consensus target price of $28.62, suggesting a potential upside of 2.42%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 3.67%. Given Envista's higher probable upside, equities analysts plainly believe Envista is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

Summary

Envista beats Alpha Tau Medical on 11 of the 14 factors compared between the two stocks.

How does Alpha Tau Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

2.7% of Alpha Tau Medical shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

iRhythm Technologies has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its share price is 17% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. iRhythm Technologies' return on equity of -10.26% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-3.53% -10.26% -1.39%
Alpha Tau Medical N/A -73.23%-52.90%

iRhythm Technologies presently has a consensus price target of $184.71, suggesting a potential upside of 45.30%. Alpha Tau Medical has a consensus price target of $12.60, suggesting a potential downside of 3.67%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts clearly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

In the previous week, iRhythm Technologies had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for iRhythm Technologies and 3 mentions for Alpha Tau Medical. iRhythm Technologies' average media sentiment score of 1.13 beat Alpha Tau Medical's score of -0.10 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Alpha Tau Medical has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M5.59-$44.55M-$0.86N/A
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

Summary

iRhythm Technologies beats Alpha Tau Medical on 10 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation.

Alpha Tau Medical has a net margin of 0.00% compared to Establishment Labs' net margin of -19.05%. Alpha Tau Medical's return on equity of -73.23% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Establishment Labs-19.05% -218.77% -12.31%
Alpha Tau Medical N/A -73.23%-52.90%

In the previous week, Establishment Labs had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for Establishment Labs and 3 mentions for Alpha Tau Medical. Establishment Labs' average media sentiment score of 0.73 beat Alpha Tau Medical's score of -0.10 indicating that Establishment Labs is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Establishment Labs
2 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Alpha Tau Medical has lower revenue, but higher earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Establishment Labs$211.08M13.19-$51.06M-$1.49N/A
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A

Establishment Labs presently has a consensus target price of $93.75, suggesting a potential downside of 0.91%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 3.67%. Given Establishment Labs' stronger consensus rating and higher possible upside, research analysts clearly believe Establishment Labs is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Establishment Labs
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

Establishment Labs has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Establishment Labs beats Alpha Tau Medical on 8 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Warby Parker?

Alpha Tau Medical (NASDAQ:DRTS) and Warby Parker (NYSE:WRBY) are related companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 93.2% of Warby Parker shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 16.8% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential downside of 3.67%. Warby Parker has a consensus target price of $29.82, indicating a potential downside of 0.46%. Given Warby Parker's stronger consensus rating and higher possible upside, analysts plainly believe Warby Parker is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
Warby Parker
0 Sell rating(s)
5 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.64

Warby Parker has a net margin of 0.15% compared to Alpha Tau Medical's net margin of 0.00%. Warby Parker's return on equity of 2.30% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
Warby Parker 0.15%2.30%1.18%

In the previous week, Warby Parker had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for Warby Parker and 3 mentions for Alpha Tau Medical. Warby Parker's average media sentiment score of 0.80 beat Alpha Tau Medical's score of -0.10 indicating that Warby Parker is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Warby Parker
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Warby Parker has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
Warby Parker$871.91M3.68$1.64M$0.021,497.85

Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.92, suggesting that its stock price is 92% more volatile than the broader market.

Summary

Warby Parker beats Alpha Tau Medical on 14 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to TransMedics Group?

Alpha Tau Medical (NASDAQ:DRTS) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, media sentiment, profitability, risk, earnings, analyst recommendations, dividends and valuation.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

TransMedics Group has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$0.67N/A
TransMedics Group$605.49M4.61$190.29M$4.4018.35

Alpha Tau Medical presently has a consensus target price of $12.60, indicating a potential downside of 3.67%. TransMedics Group has a consensus target price of $126.27, indicating a potential upside of 56.37%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts clearly believe TransMedics Group is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
TransMedics Group
1 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Alpha Tau Medical has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, meaning that its stock price is 90% more volatile than the broader market.

In the previous week, TransMedics Group had 14 more articles in the media than Alpha Tau Medical. MarketBeat recorded 17 mentions for TransMedics Group and 3 mentions for Alpha Tau Medical. TransMedics Group's average media sentiment score of 0.28 beat Alpha Tau Medical's score of -0.10 indicating that TransMedics Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
TransMedics Group
6 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

TransMedics Group has a net margin of 27.04% compared to Alpha Tau Medical's net margin of 0.00%. TransMedics Group's return on equity of 22.38% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -73.23% -52.90%
TransMedics Group 27.04%22.38%8.46%

Summary

TransMedics Group beats Alpha Tau Medical on 14 of the 15 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.18B$5.67B$6.80B$13.02B
Dividend YieldN/A1.79%2.60%10.03%
P/E Ratio-19.5223.56279.7225.54
Price / SalesN/A59.04648.71115.96
Price / CashN/A32.5328.6434.82
Price / Book14.866.5211.126.36
Net Income-$42.63M$150.91M$3.48B$347.58M
7 Day Performance13.25%6.44%2.59%3.17%
1 Month Performance-1.13%1.07%-2.79%-2.06%
1 Year Performance333.11%9.90%64.29%21.19%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
1.404 of 5 stars
$13.08
+9.7%
$12.60
-3.7%
+300.0%$1.18BN/AN/A80
NVST
Envista
2.5237 of 5 stars
$27.00
+1.3%
$28.54
+5.7%
+31.4%$4.34B$2.72B65.8512,000
IRTC
iRhythm Technologies
4.3126 of 5 stars
$117.37
+4.7%
$184.71
+57.4%
-24.4%$3.69B$747.14MN/A2,400
ESTA
Establishment Labs
1.8483 of 5 stars
$91.90
-0.2%
$90.43
-1.6%
+124.5%$2.71B$211.08MN/A1,004
WRBY
Warby Parker
2.4048 of 5 stars
$25.95
+4.4%
$29.82
+14.9%
+19.7%$2.66B$871.91M1,298.304,036

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners